Locations:
Search
Patients on ibrutinib were more than twice as likely to experience atrial fibrillation or heart failure than those on second-generation alternatives.
Expert recommendations introduce use of targeted agents
Combination therapy may soon represent new standard of care
Adequate dosing may improve outcomes in well-selected patients, large Cleveland Clinic series suggests
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Research findings offer clues for improving disease outcomes in men
Creating a safe space for patients
Long-term immune effects reshape preventative strategies and timelines
Large-scale database also reveals potential for immunotherapy to protect against cancer
Findings may help guide discussions around prognosis and allogeneic stem cell transplantation
Research underscores the importance of access to timely diagnosis and treatment in this patient population.
Advertisement
Advertisement